AG021661/AG/NIA NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2004	3
2005	2
2006	5
2007	1
2024	0

1

Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, Berry RW. Binder LI, et al. Biochim Biophys Acta. 2005 Jan 3;1739(2-3):216-23. doi: 10.1016/j.bbadis.2004.08.014. Biochim Biophys Acta. 2005. PMID: 15615640 Free article. Review.

2

Single-cell gene expression analysis: implications for neurodegenerative and neuropsychiatric disorders.

Ginsberg SD, Elarova I, Ruben M, Tan F, Counts SE, Eberwine JH, Trojanowski JQ, Hemby SE, Mufson EJ, Che S. Ginsberg SD, et al. Neurochem Res. 2004 Jun;29(6):1053-64. doi: 10.1023/b:nere.0000023593.77052.f7. Neurochem Res. 2004. PMID: 15176463 Review.

3

Degradation of tau protein by puromycin-sensitive aminopeptidase in vitro.

Sengupta S, Horowitz PM, Karsten SL, Jackson GR, Geschwind DH, Fu Y, Berry RW, Binder LI. Sengupta S, et al. Biochemistry. 2006 Dec 19;45(50):15111-9. doi: 10.1021/bi061830d. Biochemistry. 2006. PMID: 17154549

4

Formation of phospho-SAPK/JNK granules in the hippocampus is an early event in Alzheimer disease.

Lagalwar S, Guillozet-Bongaarts AL, Berry RW, Binder LI. Lagalwar S, et al. J Neuropathol Exp Neurol. 2006 May;65(5):455-64. doi: 10.1097/01.jnen.0000229236.98124.d8. J Neuropathol Exp Neurol. 2006. PMID: 16772869

5

Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.

Guillozet-Bongaarts AL, Garcia-Sierra F, Reynolds MR, Horowitz PM, Fu Y, Wang T, Cahill ME, Bigio EH, Berry RW, Binder LI. Guillozet-Bongaarts AL, et al. Neurobiol Aging. 2005 Jul;26(7):1015-22. doi: 10.1016/j.neurobiolaging.2004.09.019. Epub 2004 Dec 16. Neurobiol Aging. 2005. PMID: 15748781

6

Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.

Lagalwar S, Berry RW, Binder LI. Lagalwar S, et al. Acta Neuropathol. 2007 Jan;113(1):63-73. doi: 10.1007/s00401-006-0159-4. Epub 2006 Nov 7. Acta Neuropathol. 2007. PMID: 17089132

7

Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.

Horowitz PM, Patterson KR, Guillozet-Bongaarts AL, Reynolds MR, Carroll CA, Weintraub ST, Bennett DA, Cryns VL, Berry RW, Binder LI. Horowitz PM, et al. J Neurosci. 2004 Sep 8;24(36):7895-902. doi: 10.1523/JNEUROSCI.1988-04.2004. J Neurosci. 2004. PMID: 15356202 Free PMC article.

8

Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies.

Reynolds MR, Reyes JF, Fu Y, Bigio EH, Guillozet-Bongaarts AL, Berry RW, Binder LI. Reynolds MR, et al. J Neurosci. 2006 Oct 18;26(42):10636-45. doi: 10.1523/JNEUROSCI.2143-06.2006. J Neurosci. 2006. PMID: 17050703 Free PMC article.

9

Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.

Guillozet-Bongaarts AL, Cahill ME, Cryns VL, Reynolds MR, Berry RW, Binder LI. Guillozet-Bongaarts AL, et al. J Neurochem. 2006 May;97(4):1005-14. doi: 10.1111/j.1471-4159.2006.03784.x. Epub 2006 Apr 5. J Neurochem. 2006. PMID: 16606369 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

9 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year